Assertio Holdings (ASRT) EBIT Margin Growth (3y) (2022 - 2026)

Assertio Holdings (ASRT) EBIT Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1,673.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -37.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,442.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 13,036.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 5,091.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 5,310.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -11,841.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -698.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2,466.00
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn -19,688.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -19,688.00
Dec 31, 2025 -10,786.00
Sep 30, 2025 440.00
Jun 30, 2025 -5,821.00
Mar 31, 2025 -8,159.00
Dec 31, 2024 -6,581.00
Sep 30, 2024 -3,373.00
Jun 30, 2024 3,568.00
Mar 31, 2024 -4,134.00
Dec 31, 2023 1,167.00
Sep 30, 2023 -62,141.00
Jun 30, 2023 15,521.00
Mar 31, 2023 9,045.00
Dec 31, 2022 34,356.00
Sep 30, 2022 3,718.00
Jun 30, 2022 2,439.00